Cardinal Health, Inc. (CAH): Price and Financial Metrics
Cardinal Health, Inc. (CAH)
Today's Latest Price: $55.24 USD
Updated Jan 27 2:47pm
Add CAH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 77 in Medical - Services
See all "A" rated Strong Buy stocks
CAH Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for CAH is 108.75 -- better than 99.86% of US stocks.
- With a price/sales ratio of 0.11, Cardinal Health Inc has a higher such ratio than only 1.83% of stocks in our set.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 30.42 for Cardinal Health Inc; that's greater than it is for 98.85% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Cardinal Health Inc are EXTR, HYRE, NSP, CLPT, and REED.
- CAH's SEC filings can be seen here. And to visit Cardinal Health Inc's official web site, go to www.cardinalhealth.com.
CAH Stock Price Chart Interactive Chart >
CAH Price/Volume Stats
| Current price | $55.24 | 52-week high | $60.69 |
| Prev. close | $55.48 | 52-week low | $39.05 |
| Day low | $54.71 | Volume | 1,466,509 |
| Day high | $55.62 | Avg. volume | 1,740,030 |
| 50-day MA | $54.69 | Dividend yield | 3.5% |
| 200-day MA | $52.01 | Market Cap | 16.21B |
Cardinal Health, Inc. (CAH) Company Bio
Cardinal Health provides pharmaceutical and medical products and services that help pharmacies, hospitals and other healthcare providers focus on patient care. The company was founded in 1979 and is based in Dublin, Ohio.
CAH Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $55.24 | $85.41 | 54% |
Below please find a table outlining a discounted cash flow forecast for CAH, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Cardinal Health Inc ranked in the 61th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 54.5% on a DCF basis. In terms of the factors that were most noteworthy in this DCF analysis for CAH, they are:
- The stock's equity weight, or the proportion of capital from equity relative to debt, is 71. Notably, its equity weight is greater than merely 21.92% of US equities in the Healthcare sector yielding a positive free cash flow.
- Cardinal Health Inc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than merely 9.09% of tickers in our DCF set.
- Cardinal Health Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 51% |
| 1% | 52% |
| 2% | 54% |
| 3% | 55% |
| 4% | 57% |
| 5% | 58% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CAH, try ANIP, RDNT, MCK, ANTM, and DGX.
Loading social stream, please wait...